Literature DB >> 26903544

Krüppeling erythropoiesis: an unexpected broad spectrum of human red blood cell disorders due to KLF1 variants.

Andrew Perkins1, Xiangmin Xu2, Douglas R Higgs3, George P Patrinos4, Lionel Arnaud5, James J Bieker6, Sjaak Philipsen7.   

Abstract

Until recently our approach to analyzing human genetic diseases has been to accurately phenotype patients and sequence the genes known to be associated with those phenotypes; for example, in thalassemia, the globin loci are analyzed. Sequencing has become increasingly accessible, and thus a larger panel of genes can be analyzed and whole exome and/or whole genome sequencing can be used when no variants are found in the candidate genes. By using such approaches in patients with unexplained anemias, we have discovered that a broad range of hitherto unrelated human red cell disorders are caused by variants in KLF1, a master regulator of erythropoiesis, which were previously considered to be extremely rare causes of human genetic disease.
© 2016 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26903544      PMCID: PMC4832505          DOI: 10.1182/blood-2016-01-694331

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  64 in total

1.  Silencing of human fetal globin expression is impaired in the absence of the adult beta-globin gene activator protein EKLF.

Authors:  A C Perkins; K M Gaensler; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

2.  Compound heterozygosity for KLF1 mutations is associated with microcytic hypochromic anemia and increased fetal hemoglobin.

Authors:  Jiwei Huang; Xinhua Zhang; Dun Liu; Xiaofeng Wei; Xuan Shang; Fu Xiong; Lihua Yu; Xiaolin Yin; Xiangmin Xu
Journal:  Eur J Hum Genet       Date:  2015-01-14       Impact factor: 4.246

3.  Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster.

Authors:  S H Orkin; H H Kazazian; S E Antonarakis; S C Goff; C D Boehm; J P Sexton; P G Waber; P J Giardina
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

4.  Levels of Hb A2 in heterozygotes and homozygotes for beta-thalassemia mutations: influence of mutations in the CACCC and ATAAA motifs of the beta-globin gene promoter.

Authors:  T H Huisman
Journal:  Acta Haematol       Date:  1997       Impact factor: 2.195

5.  The role of EKLF in human beta-globin gene competition.

Authors:  M Wijgerde; J Gribnau; T Trimborn; B Nuez; S Philipsen; F Grosveld; P Fraser
Journal:  Genes Dev       Date:  1996-11-15       Impact factor: 11.361

6.  A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Krüppel family of nuclear proteins.

Authors:  I J Miller; J J Bieker
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

7.  Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF.

Authors:  A C Perkins; A H Sharpe; S H Orkin
Journal:  Nature       Date:  1995-05-25       Impact factor: 49.962

8.  Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene.

Authors:  B Nuez; D Michalovich; A Bygrave; R Ploemacher; F Grosveld
Journal:  Nature       Date:  1995-05-25       Impact factor: 49.962

9.  Analyses of beta-thalassemia mutant DNA interactions with erythroid Krüppel-like factor (EKLF), an erythroid cell-specific transcription factor.

Authors:  W C Feng; C M Southwood; J J Bieker
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

10.  Role of erythroid Kruppel-like factor in human gamma- to beta-globin gene switching.

Authors:  D Donze; T M Townes; J J Bieker
Journal:  J Biol Chem       Date:  1995-01-27       Impact factor: 5.157

View more
  42 in total

1.  Neomorphic effects of the neonatal anemia (Nan-Eklf) mutation contribute to deficits throughout development.

Authors:  Antanas Planutis; Li Xue; Cecelia D Trainor; Mohan Dangeti; Kevin Gillinder; Miroslawa Siatecka; Danitza Nebor; Luanne L Peters; Andrew C Perkins; James J Bieker
Journal:  Development       Date:  2017-02-01       Impact factor: 6.868

Review 2.  Orchestration of late events in erythropoiesis by KLF1/EKLF.

Authors:  Merlin Nithya Gnanapragasam; James J Bieker
Journal:  Curr Opin Hematol       Date:  2017-05       Impact factor: 3.284

3.  Single cell transcriptomics reveals unanticipated features of early hematopoietic precursors.

Authors:  Jennifer Yang; Yoshiaki Tanaka; Montrell Seay; Zhen Li; Jiaqi Jin; Lana Xia Garmire; Xun Zhu; Ashley Taylor; Weidong Li; Ghia Euskirchen; Stephanie Halene; Yuval Kluger; Michael P Snyder; In-Hyun Park; Xinghua Pan; Sherman Morton Weissman
Journal:  Nucleic Acids Res       Date:  2017-02-17       Impact factor: 16.971

4.  KLF1/EKLF expression in acute leukemia is correlated with chromosomal abnormalities.

Authors:  Adnan Mansoor; Mohammad Omer Mansoor; Jay L Patel; Shuchun Zhao; Yasodha Natkunam; James J Bieker
Journal:  Blood Cells Mol Dis       Date:  2020-04-13       Impact factor: 3.039

Review 5.  Molecular basis of β thalassemia and potential therapeutic targets.

Authors:  Swee Lay Thein
Journal:  Blood Cells Mol Dis       Date:  2017-06-20       Impact factor: 3.039

6.  A Krüppel-like factor 1 (KLF1) Mutation Associated with Severe Congenital Dyserythropoietic Anemia Alters Its DNA-Binding Specificity.

Authors:  Klaudia Kulczynska; James J Bieker; Miroslawa Siatecka
Journal:  Mol Cell Biol       Date:  2020-02-12       Impact factor: 4.272

7.  Mutations in the zebrafish hmgcs1 gene reveal a novel function for isoprenoids during red blood cell development.

Authors:  Jose A Hernandez; Victoria L Castro; Nayeli Reyes-Nava; Laura P Montes; Anita M Quintana
Journal:  Blood Adv       Date:  2019-04-23

8.  Epo reprograms the epigenome of erythroid cells.

Authors:  Andrea A Perreault; Mary Lauren Benton; Mark J Koury; Stephen J Brandt; Bryan J Venters
Journal:  Exp Hematol       Date:  2017-04-12       Impact factor: 3.084

Review 9.  Development of autologous blood cell therapies.

Authors:  Ah Ram Kim; Vijay G Sankaran
Journal:  Exp Hematol       Date:  2016-06-21       Impact factor: 3.084

10.  A master erythroid regulator gets its own GPS.

Authors:  Lily Jun-Shen Huang; James J Bieker
Journal:  Blood       Date:  2020-06-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.